Clinical Trial Update: Bioequivalence Between Two Oral Nicotine Sublingual Tablets, 2 mg and 4 mg [NA]

View source ↗

Summary

A completed bioequivalence study compared 2 mg and 4 mg oral nicotine sublingual tablets to determine if they deliver nicotine equivalently.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Nicotine sublingual tablet 2 mg (Nicotine)
• Nicotine sublingual tablet 4 mg (Nicotine)

Snippet

Sponsor: McNeil AB | Conditions: Tobacco Dependence | NA | Status: COMPLETED